CompoSecure’s Pioneering Security and Innovative Payment Solutions Win Two Prestigious Awards
September 16, 2024 08:00 ET
|
CompoSecure, Inc.
SOMERSET, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its recognition at The...
Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
September 16, 2024 08:00 ET
|
Apollomics Inc.
FOSTER CITY, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology...
Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies
September 16, 2024 08:00 ET
|
Palisade Bio, Inc.
– Company remains committed to its mission to become a leader in developing differentiated product candidates targeting immune, inflammatory and fibrotic diseases – Successful completion of...
Coda Octopus Group Reports Fiscal Third Quarter 2024 Financial Results
September 16, 2024 08:00 ET
|
Coda Octopus Group, Inc.
ORLANDO, FL, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in real-time 4D/5D/6D imaging sonar technology for real-time...
Lotus Robotics Selected to Supply to a World-Class Japanese Tier-One Supplier
September 16, 2024 08:00 ET
|
Lotus Technology Inc.
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent luxury mobility provider, today announced that its...
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
September 16, 2024 08:00 ET
|
Actuate Therapeutics
Preclinical Study Highlight the Potential of Elraglusib in Overcoming FOLFIRINOX-induced Chemoresistance Through Downregulation of Epithelial to Mesenchymal Transition (EMT)Initial Data Demonstrates...
Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
September 16, 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by Seniors
September 16, 2024 08:00 ET
|
InnovAge
A new study, involving InnovAge, works to reduce deadly falls in seniors, as well as help adults living with disabilities and chronic conditions.
InterDigital Announces Annual Recurring Revenue Target Of $1 Billion By 2030
September 16, 2024 08:00 ET
|
InterDigital, Inc.
WILMINGTON, Del., Sept. 16, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, has announced targets of $1 billion in...
Vertex remporte les prix Meilleur de sa catégorie et Région Amérique du Nord dans la catégorie Innovation lors des Oracle Partner Awards 2024
September 16, 2024 08:00 ET
|
Vertex Inc.
KING OF PRUSSIA, État de Pennsylvanie, 16 sept. 2024 (GLOBE NEWSWIRE) -- Vertex, Inc.(NASDAQ : VERX), ci-après « Vertex » ou « la Société », fournisseur mondial de technologies dans le domaine...